Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04593693 · ClinicalTrials.gov registry record · NA
A Dual-center Study Evaluating Clinical Acceptance of a NPWT Wound Care System
A NA study, sponsored by Medela.
- Completed
- Registry status
- NA
- Development phase
- 25
- Enrollment target
NCT04593693 is a NA study that has completed, run by Medela. The registered enrollment target is 25 participants.
The verdict
NCT04593693, a NA study, has completed, sponsored by Medela.
- COMPLETED
- Registry status
- NA
- Development phase
- 25 participants
- Enrollment target
Study Summary
The purpose of this study is to determine if use of the Medela Invia Motion NPWT system supports acceptable progress towards the goal of therapy when treating patients with a variety of wound types during the evaluation period.
Interventions
- DEVICE Invia Motion Endure NPWT system
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 25 participants |
| Start Date | 2020-12-10 |
| Est. Completion | 2021-05-18 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT04593693
The ClinicalTrials.gov registry entry for NCT04593693 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 25 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Medela, which has 2 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Invia Motion Endure NPWT system is the first listed.
NCT04593693 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT04593693 about?
NCT04593693 is a clinical study titled "A Dual-center Study Evaluating Clinical Acceptance of a NPWT Wound Care System". The purpose of this study is to determine if use of the Medela Invia Motion NPWT system supports acceptable progress towards the goal of therapy when treating patients with a variety of wound types during the evaluation period.
What is the current status of trial NCT04593693?
This trial is currently completed. It is a NA study. The enrollment target is 25 participants. The study started on 2020-12-10. Estimated completion is 2021-05-18.
What interventions are being tested in trial NCT04593693?
The interventions under investigation include: Invia Motion Endure NPWT system (DEVICE).
Who is sponsoring clinical trial NCT04593693?
This trial is sponsored by Medela, which has 2 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.